Welcome to our dedicated page for BrightSpring Health Services SEC filings (Ticker: BTSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BrightSpring Health Services, Inc. (NASDAQ: BTSG) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, shelf registration statements, prospectus supplements, and other materials that describe BrightSpring’s financial results, capital markets activity, and significant corporate events.
BrightSpring uses Form 8-K to report quarterly financial results and preliminary financial information, furnishing press releases that summarize revenue, segment performance for Pharmacy Solutions and Provider Services, and non-GAAP measures such as EBITDA and Adjusted EBITDA. These filings explain how the company distinguishes its continuing operations from its Community Living business and how this affects its reported metrics and guidance.
The company also files 8-Ks to describe material agreements and capital markets transactions. For example, BrightSpring has disclosed underwriting agreements related to secondary offerings of common stock by existing stockholders, as well as concurrent share repurchases executed through the underwriter. These filings outline the number of shares involved, the role of selling stockholders, and the use of an automatic shelf registration statement on Form S-3ASR.
Other 8-K filings address matters such as changes in certain leadership roles within BrightSpring’s subsidiaries and related compensatory arrangements. These disclosures can provide additional context on management and governance developments within the organization.
On Stock Titan, BrightSpring filings are updated as they are made available on EDGAR, and AI-powered tools can help summarize the key points from lengthy documents. Users can quickly see what each filing covers, from earnings releases and guidance updates to underwriting agreements and leadership changes, and then review the full text for more detailed analysis of BTSG’s regulatory and financial reporting.
BrightSpring Health Services, Inc. director Steven B. Miller reported a compensation-related equity grant. On May 5, 2026, he acquired 4,983 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock upon settlement. These RSUs fully vest on May 5, 2027. Following this award, Miller holds 23,106 shares of BrightSpring common stock directly.
KIRTLEY OLIVIA F reported acquisition or exercise transactions in this Form 4 filing.
BrightSpring Health Services director Olivia F. Kirtley received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. After this award, she directly holds 36,997 shares of BrightSpring common stock.
Each RSU represents a contingent right to receive one share of BrightSpring common stock upon settlement, so the grant functions as equity-based compensation rather than a cash transaction.
Wicks Timothy A reported acquisition or exercise transactions in this Form 4 filing.
BrightSpring Health Services director Timothy A. Wicks received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. Following this award, Wicks directly holds 25,504 shares of BrightSpring common stock.
Each RSU represents a contingent right to receive one share of common stock upon settlement. Wicks has elected to defer settlement under BrightSpring’s Non-Employee Director Deferred Compensation Plan, so the shares will be delivered after his board service ends or on a future date he previously selected.
FMR LLC reported ownership of 21,200,804.91 shares of BrightSpring Health Services Inc. common stock, representing 10.9% of the class as disclosed on this Schedule 13G/A. The filing lists sole voting power of 21,177,426.33 shares and sole dispositive power of 21,200,804.91 shares. The cover cites CUSIP 10950A106 and an issuer address in Louisville, Kentucky. The report is signed under a Power of Attorney and references Exhibit 99 for a related agreement.
BrightSpring Health Services delivered strong first-quarter 2026 results, combining organic growth with a major portfolio reshaping. Revenue rose 25.6% to $3.6 billion, with Pharmacy Solutions up 25.2% to $3.2 billion and Provider Services up 27.9% to $442.4 million.
Income from continuing operations climbed to $74.3 million, while total net income reached $148.6 million, helped by a $103.4 million pre-tax gain on the sale of the Community Living business. Diluted EPS from continuing operations increased to $0.34, and Adjusted EBITDA grew 44.8% to $189.8 million, reflecting better scale and margins in both segments.
The Community Living divestiture generated $810.9 million of cash proceeds and is treated as discontinued operations. Cash and cash equivalents rose to $888.8 million against total debt of about $2.56 billion, resulting in reported leverage of 2.27x. The company also repurchased 1.46 million shares for $60 million alongside a 20 million–share secondary offering by existing holders.
BrightSpring Health Services reported sharply improved first quarter 2026 results and raised its full year outlook. Total revenue reached $3.61 billion for the quarter ended March 31, 2026, compared with $2.88 billion a year earlier, with growth in both products and services.
Net income rose to $148.6 million from $29.0 million, including higher income from continuing and discontinued operations. Adjusted EBITDA increased to $189.8 million, up from $131.1 million, while diluted EPS from continuing operations was $0.34 and Adjusted EPS was $0.39. Operating cash flow strengthened to $122.9 million, and cash and cash equivalents climbed to $888.8 million.
For full year 2026, the company now guides to revenue of $14.7–$15.2 billion and total Adjusted EBITDA of $795–$825 million, both higher than prior 2025 results on a comparable basis. Management expects the Amedysis and LHC acquisition to contribute about $30 million of Adjusted EBITDA in 2026.
BrightSpring Health Services, Inc. director and officer Jon B. Rousseau reported a routine equity compensation event. In connection with the vesting of 125,012 restricted stock units, the company withheld 16,222 shares of common stock to cover tax obligations at a net settlement price equal to the $48.16 closing price on April 24, 2026. Following these tax-withholding dispositions, Rousseau directly owns 1,194,503 shares of common stock and has an additional 369,763 shares held indirectly through the Rousseau Family Trust, for which he disclaims beneficial ownership beyond his pecuniary interest.
BrightSpring Health Services, Inc. is asking stockholders to vote at its virtual Annual Meeting on May 21, 2026 on three items: electing three Class II directors to serve until 2029, ratifying KPMG LLP as independent auditor for 2026, and approving on an advisory basis executive compensation.
The company reports strong 2025 performance, with revenue rising to $12.9 billion and Adjusted EBITDA increasing to $618 million, driven mainly by its pharmacy solutions and provider services segments. Executive pay centers on a short‑term incentive plan tied to EBITDA, revenue growth and a quality index, with CEO base salary set at $1.4 million and a 150% target bonus opportunity. BrightSpring is no longer a Nasdaq “controlled company” after the KKR stockholder fell below majority ownership in 2025, and has formed fully independent audit and compensation committees while using a transition period to finalize a nominating and governance charter.
BlackRock, Inc. filed Amendment No. 1 to Schedule 13G/A reporting beneficial ownership of 20,564,901 shares of BrightSpring Health Services Inc common stock, equal to 10.6% of the class. The filing shows sole voting power for 20,367,931 shares and sole dispositive power for 20,564,901 shares. The amendment is signed by Spencer Fleming on 04/07/2026 and states the holdings reflect securities held by certain Reporting Business Units of BlackRock, Inc.